Trends in the Treatment of Multiple Myeloma
THURSDAY, SEPT. 11, 2014
Sagar Lonial, MD, Emory University
Over the past two decades, new medications approved by the U.S. Food and Drug Administration (FDA) have transformed the way multiple myeloma is treated. This progress is unmatched in any other type of cancer. Researchers expect the picture for people with multiple myeloma to improve even more as new drugs and drug combinations are studied in clinical trials. This session will discuss recent advances in pharmacologic treatment and the roll of stem cell transplantation for multiple myeloma.
- Discuss recent advances in pharmacologic treatment for multiple myeloma.
- Identify the roll of stem cell transplantation for multiple myeloma.
These materials are intended ONLY for pharmacists and pharmacy technicians that attended the presentation, "Trends in the Treatment of Multiple Myeloma" held at 2:30 p.m. Thur., Sept. 11, 2014. This session was part of the "23rd Annual National Conference" held in Chicago, Ill. on Sept. 10-12, 2014.
The prerequisite to this process is completing the 23rd Annual National Conference Post-Assessment and Evaluation. If there is a Prerequisite section above and the Status field is blank, click on '23rd Annual National Conference' to open the Assessment and Evaluation.
- 1.00 ACPE - Pharmacists